Search Results 71-80 of 10767 for ���������������������������:ZA31���

  1. Comparative Analysis of Zero Echo-time MRI and CT for Patient Diagnosis and Intervention. - Mayo Clinic

    About this study. Zero echo time (ZTE) is seen as a viable radiation-free alternative to a CT scan. This study will investigate this opportunity by ...

  2. Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis - Mayo Clinic

    The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...

  3. Metastatic Prostate Cancer Clinical Trials - Mayo Clinic Research

    The purpose of this study is to determine if salvage stereotactic body radiotherapy (SBRT) is non-inferior to moderately hypofractionated radiation therapy ( ...

  4. A Study To Investigate LP352 In Children And Adults With Developmental And Epileptic Encephalopathy (DEE) - Mayo Clinic

    About this study. This (DEEp OLE Study) is a multicentre, open-label study to investigate the long-term safety, efficacy, tolerability, and pharmacokinetics ...

  5. A Study to Assess Clonal Diversity of Freshly Taken ESD Specimens - Mayo Clinic

    Inclusion Criteria: Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) ...

  6. Oncology (Medical) - Clinical trials

    Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.

  7. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

    TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...

  8. Z-Endoxifen Hydrochloride in Treating Patients with Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer - Mayo Clinic

    Hormone therapy using Z-endoxifen hydrochloride may fight breast cancer by blocking the use of estrogen by tumor cells. Participation eligibility. Participant ...

  9. Inhibiting HDAC6 and HDAC1 upregulates RhoB with divergent downstream targets, BIM or p21WAF1/CIP1, leading to either apoptosis

    Background: Anaplastic thyroid carcinoma (ATC) is a highly aggressive undifferentiated carcinoma with a mortality rate near 100%. This high.

  10. A Study of CMB305 and Atezolizumab in Patients with Sarcoma - Mayo Clinic

    CMB305 is a novel approach designed to stimulate the body's immune system to fight the spread and growth of cancer in patients whose tumors express the NY-ESO-1 ...